Retatrutide Pen 30mg / 2.4ml

Retatrutide is a single-molecule agonist of the GLP-1, GIP and glucagon receptors. Acting on 3 receptors at once, it slows gastric emptying, increases satiety signalling and raises energy expenditure; phase 2 data (Jastreboff et al., NEJM 2023) reported dose-dependent weight reduction over 48 weeks.

In practice this is the most potent incretin-class compound currently studied for body-composition protocols. Dose titration is gradual and should be supervised.

Presentation

• Format: Pre-filled injection pen
• Strength: 30mg / 2.4ml
• Storage: refrigerate at 2–8 °C; keep away from light

Supplied to healthcare professionals and their patients for use under medical supervision. Product information is educational and does not replace clinical judgement.